Brochure | March 8, 2021

Q2 Solutions Companion Diagnostics Expertise

Source: Q2 Solutions

Companion diagnostics (CDx) enable personalized medicine by identifying likely patient responders based on efficacy and safety. Guidance recommends that sponsors consider CDx early in drug development, and to plan for co-development of the product with a companion diagnostic. Q2 Solutions has successfully supported drug developers in many clinical development programs globally, from the early stages of biomarker identification through clinical trials testing and commercialization. Download the brochure to read more about our CDx services and expertise.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader